From: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer
Parameters | Â | VEGF | P value | MVD (CD34) | P value | |||
---|---|---|---|---|---|---|---|---|
 |  | (-) | (1+) | (2+) | (3+) |  | (mean ± S.D.) | (ANOVA) |
Total | 114 | 31 | 27 | 22 | 34 |  | 11.60 ± 5.68 |  |
Age | Â | Â | Â | Â | Â | 0.612 | Â | 0.319 |
< 59 | 48 | 11 | 10 | 10 | 17 |  | 12.23 ± 6.19 |  |
≥ 59 | 66 | 20 | 17 | 12 | 17 |  | 11.15 ± 5.28 |  |
Tumor differentiation | Â | Â | Â | Â | Â | 0.112 | Â | 0.952 |
low | 16 | 6 | 2 | 3 | 5 |  | 11.24 ± 7.30 |  |
moderate | 68 | 16 | 18 | 9 | 25 |  | 11.72 ± 5.30 |  |
high | 30 | 9 | 7 | 10 | 4 |  | 11.53 ± 5.75 |  |
Lymph node metastasis | Â | Â | Â | Â | Â | 0.001 | Â | 0.879 |
N0 | 65 | 23 | 20 | 13 | 9 |  | 11.80 ± 5.54 |  |
N1 | 36 | 7 | 6 | 7 | 16 |  | 11.20 ± 6.74 |  |
N2 | 13 | 1 | 1 | 2 | 9 |  | 11.74 ± 2.59 |  |
depth of invasion | Â | Â | Â | Â | Â | 0.601 | Â | 0.281 |
T2 | 15 | 5 | 3 | 4 | 3 |  | 11.28 ± 5.63 |  |
T3 | 88 | 24 | 21 | 14 | 29 |  | 11.33 ± 5.66 |  |
T4 | 11 | 2 | 3 | 4 | 2 |  | 14.20 ± 5.72 |  |
TNM staging | Â | Â | Â | Â | Â | 0.002 | Â | 0.295 |
I | 11 | 4 | 3 | 3 | 1 |  | 12.00 ± 6.00 |  |
II | 47 | 17 | 15 | 8 | 7 |  | 10.99 ± 4.70 |  |
III | 44 | 8 | 6 | 6 | 24 |  | 11.04 ± 6.26 |  |
IV | 12 | 2 | 3 | 5 | 2 |  | 14.26 ± 5.46 |  |
SPARC in MSC | Â | Â | Â | Â | Â | 0.0001 | Â | 0.027 |
low reactivity | 61 | 17 | 6 | 13 | 25 |  | 12.69 ± 5.71 |  |
high reactivity | 53 | 14 | 21 | 9 | 9 |  | 10.34 ± 5.43 |  |